🔎 Trials Near Me

Home › Metabolic Disorders › Texas

Metabolic Disorders clinical trials in Texas

7 studies for Metabolic Disorders are looking for participants at sites in Texas.

Cities in Texas

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
  • VIP Trials, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Amarillo
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • and 30 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Amarillo
  • 89bio Clinical Study Site, Austin
  • 89bio Clinical Study Site, Austin
  • and 21 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374

Genetic and Metabolic Disease in Children

  • Children's Medical Center at Dallas, Dallas
RecruitingObservational study
1 Day · All sexes · Updated Jul 2, 2026 · NCT02650622

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

  • Texas Children's Hospital, Houston
RecruitingPhase 1/2
Ages 1 and older · All sexes · Updated Mar 23, 2026 · NCT05130437

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • Texas Children's Hospital, Houston
RecruitingPhase 1/2
All ages · All sexes · Updated Jan 22, 2026 · NCT04159103

Rare and Atypical Diabetes Network

  • Baylor College of Medicine, Houston
RecruitingObservational study
All ages · All sexes · Updated Aug 14, 2025 · NCT05544266

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.